导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -11.28% | 848/1050 |
| 近一周 | -3.27% | 851/1104 |
| 近一月 | -6.84% | 803/1102 |
| 近一季 | -3.30% | 364/1092 |
| 近半年 | -12.35% | 826/1070 |
| 近一年 | -18.38% | 877/1018 |
| 近两年 | 9.79% | 840/926 |
| 近三年 | -13.62% | 748/834 |
| 成立以来 | -15.31% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-3.66% 751/1070 |
-7.46% 852/1101 |
- - |
- - |
| 2025 | 6.99% 859/1065 |
1.98% 649/1014 |
0.45% 654/1038 |
11.70% 816/1050 |
-6.49% 770/1065 |
| 2024 | -1.76% 631/1011 |
-2.50% 445/960 |
-2.40% 465/983 |
10.40% 595/991 |
-6.49% 755/1011 |
| 2023 | -19.03% 651/952 |
2.40% 483/880 |
-4.12% 461/895 |
-12.65% 706/915 |
-5.59% 567/952 |
| 2022 | -20.35% 336/867 |
-16.50% 331/773 |
4.27% 563/806 |
-11.65% 362/845 |
3.56% 260/867 |
| 2021 | -16.87% 524/740 |
-1.66% 210/580 |
3.09% 500/659 |
-14.84% 607/704 |
-3.70% 559/740 |
| 2020 | 47.91% 247/554 |
-1.21% 192/419 |
19.05% 302/466 |
12.60% 191/517 |
11.68% 305/554 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 招商核心优选股票A VS. 东吴新产业精选股票A(580008) |